Home
About
Overview
Sharing Data
ORCID
Help
History (11)
Intra-aortic balloon pump counterpulsation in the setting of subarachnoid hemorrhage, cerebral vasospasm, and neurogenic stress cardiomyopathy. Case report and review of the literature.
Modular Nanomedicines Based on Heterogeneous Fusion Protein Co-Assembly
Chung, Jonathan
Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation Study.
A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression.
A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression. Sci Transl Med. 2021 06 09; 13(597).
View in:
PubMed
subject areas
Antidepressive Agents
Depression
Depressive Disorder, Major
Double-Blind Method
Humans
Nitrous Oxide
Treatment Outcome
authors with profiles
Robert Gibbons
Nisha Jain
Peter Nagele